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Abstract: Apgar score was devised with the aim to standardize the assessment of newborns. 
It has been used worldwide to evaluate infants’ condition immediately after birth, to determine 
their need for resuscitation, and to evaluate the effectiveness of resuscitation. Apgar score was 
never intended for prediction of outcome beyond the immediate postnatal period; however, since 
low scores correlate with prenatal and perinatal adversities, multiple studies have examined the 
relation between the value of Apgar score and duration of low (7) Apgar score and subsequent 
death or neurologic disability. This article reviews such studies. The author concludes that 
the overall evidence shows consistent association of low Apgar scores with increased risks of 
neonatal and infant death and with neurologic disability, including cerebral palsy, epilepsy, 
and cognitive impairment. Dose-response patterns have been shown for the value of Apgar 
score and duration of low score and the outcomes of mortality and neurologic disability. The 
association of Apgar score 7 at five minutes with increased risks of neurologic disability seems 
to persist many years postnatally. Some corresponding relative risk estimates are large (eg, four 
to seven for epilepsy or more than 20 for cerebral palsy), while others are modest (eg, 1.33 for 
impaired cognitive function). The absolute risks, however, are low (5% in for most neurologic 
conditions), and majority of surviving babies with low Apgar scores grow up without disability. 
The low magnitude of absolute risks makes Apgar score a poor clinical predictor of long-term 
outcome. Nevertheless, the observed associations point to the importance of fetal and perinatal 
periods for neurodevelopment.
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Introduction
Motivated by lack of a method for standardized assessment of newborns, Virginia 
Apgar, an anesthesiologist at Columbia University Presbyterian Hospital in New York, 
developed and described, in a classic 1953 paper,1 her scoring system, intended “to 
predict survival” and “to compare…methods of resuscitation…and perinatal experience 
across hospitals and obstetric practices.”2 From a list of “objective signs which pertained 
in any way to the condition of the infant at birth,”1 Dr Apgar selected “five signs, which 
could be determined easily and without interfering with the care of the infant…A rating 
of zero, one or two, was given to each sign depending on whether it was absent or 
present. A score of ten indicated a baby in the best possible condition” (Figure 1).1
The five signs of the Apgar score are heart rate, respiratory effort, muscle 
tone, reflex irritability, and color. The current rating guidelines by the American 
College of Obstetrician and Gynecologists3 are given in Table 1 (the guidelines 
have changed little since the original description of the score).1 In the two reports Clinical Epidemiology 2009:1 46
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following the score description, Dr Apgar provided further 
refinement, observation, and advice regarding its use.2,4 
She also presented evidence that Apgar score did in fact 
measure condition at birth, noting, for example, the inverse 
association between the value of the score and rates of 
neonatal death.1,4
Apgar score was quickly adopted for use worldwide, 
becoming “common currency”5 among perinatologists. 
The score was initially measured at one minute after birth. 
A second measurement, at five minutes of age, was subse-
quently added, and it has been used to assist in judging the 
effectiveness of resuscitation, if initiated in response to a 
low one-minute score.2 Thus, with the exception of a small 
proportion of infants whose resuscitation begins seconds 
after birth, one-minute Apgar score reflects a natural condi-
tion at one minute after both head and feet emerge from the 
birth canal. The five-minute Apgar score reflects response 
to resuscitation among infants in whom it was initiated. 
Most, but not all, infants with a low one-minute score reach 
a five-minute score in the 7–10 range.6 If an infant does not 
improve sufficiently after five minutes, Apgar score may be 
continuously measured (for up to 25 minutes postpartum) to 
assess the effectiveness of continuing resuscitation.
In order to reduce the ‘noise’ from the partially subjective 
nature of the scoring (eg, the “color” component) Dr. Apgar 
suggested categorizing her score as low (0–3), intermediate 
(4–6), and normal (7–10).3 The categories were defined 
based on the observed neonatal mortality patterns. Because 
very small proportion of newborns have Apgar scores in the 
0–3 range, research studies often examine outcomes among 
infants with low and intermediate scores combined (7). 
Therefore, unless specified otherwise, the term ‘low Apgar 
score’ in this review will refer to a score  7.
Risk factors for low Apgar scores include abnormalities 
of gestational length and prenatal growth; congenital malfor-
mations; as well as health, demographic, and socioeconomic 
characteristics of the parents7,8 (Table 2). In developed coun-
tries, about 1% of newborns have Apgar score  7 at five 
minutes. The reported specific prevalences for year 2000 are 
0.7% in Denmark9 and 1.4% in the United States.10 The lower 
proportion of infants with scores  7 in Scandinavia may 
reflect social and ethnic homogeneity, combined with uni-
form access to obstetric care. In Sweden, an increase in the 
prevalence of five-minute Apgar scores  7 was reported 
between 1992 and 1997; explanations offered for the rise 
included increasing prevalence of multiple births, growing 
immigrant population, and more frequent use of epidural 
anesthesia.11 Higher prevalence of Apgar scores  7 is 
reported for developing countries (eg, 2.8% in Uganda),12 
indicating that the distribution of low Apgar score in the 
Table 1 Components of the Apgar score and scoring guidelines3
Sign 0 1 2
Heart rate Absent 100 100
respiratory effort Absent weak cry, hypoventilation Good, crying
Reflex irritability No response Grimace Cry or active withdrawal
Muscle tone Limp Some flexion of extremities Active motion
Color Blue, pale Body pink, extremities blue Completely pink
Figure 1 Dr  Virginia Apgar holds a newborn baby upside-down to test its reflex 
irritability – one of the five Apgar score items (1959). Copyright © 2009. Reproduced 
with permission.  Series 6 of the L. Stanley James Papers (MS 0782) in the Mount 
Holyoke College  Archives and Special Collections.   Available from: http://mtholyoke.
cdmhost.com/u?/p1030coll8,3155.Clinical Epidemiology 2009:1 47
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population may in fact reflect level of available obstetric 
care, economic situation, or nutrition.
Apgar score was never intended to be a predictor of 
long-term outcome. Nevertheless, its correlation with many 
maternal and fetal signs of prenatal and intrapartum adver-
sities (Table 2) has been repeatedly noted. Since some of 
these traits (such as prematurity) increase the risk neurologic 
disability, many studies have examined the association of 
Apgar score with neurologic sequelae. The goal of this 
article is to provide overview of evidence regarding the 
association of Apgar scores with mortality and neurologic 
disability. This review is restricted to evidence from devel-
oped countries.
Methods
Between January 1st, 1999 and February 20, 2009, there were 
1070 English-language MEDLINE-listed publications with 
abstracts containing the term ‘Apgar score’ in title or abstract. 
From these articles and those found by the related-article 
and manual searches, I primarily selected reports examin-
ing association of the Apgar score with mortality and/or 
neurologic disability published in the last 10 years. This 
period was chosen because it was judged be relevant to current 
obstetric practices. I also, however, included studies published 
before 1999, if they exemplified initial efforts to address an 
association.4,6,13–15 This review covers 17 studies,4,6,9,11,13–26 
examining the outcome of mortality (N = 6)4,6,14,16–18 and/or 
neurologic disability (N = 14).9,11,13–15,17,19–26
Results
Apgar score and mortality
Studies have consistently shown an inverse relation 
between the value of Apgar score and neonatal mortality 
(death within 28 days of life).4,6,14,16,17 The lower the value 
of Apgar score  6,14,16,17 and the longer the duration6,14 of a 
low score, the greater the proportion of infants dying neo-
natally. An early report on 17,000 infants showed that 
five-minute Apgar score had a stronger association with 
neonatal mortality than one-minute Apgar score.6 A recent 
study of 150,000 malformation-free singleton infants in 
the USA reported an inverse association between the value of 
five-minute Apgar score and the incidence of neonatal death. 
Among infants born preterm (before 37 weeks’ gestation), 
the risks of neonatal death per 1000 live births were 315, 72, 
and 6, for those with five-minute Apgar scores 0–3, 4–6, and 
7–10, respectively; among term infants (born at 37 weeks’ 
gestation or later), the corresponding estimates were 244, 9, 
and 0.2 per 1000 live births. Among term infants in that study, 
the relative risk (RR) of neonatal death associated with five-
minute Apgar score of 0–3 was RR = 1460 (95% confidence 
interval [CI]: 835–2555). This estimate was eight times 
greater than the relative risk associated with umbilical-artery 
pH  7.0, leading to the conclusion that a five-minute Apgar 
score  4 is a better predictor of neonatal death than fetal 
acidosis among term infants.16 A recent report of a Norwegian 
registry-based study of term, non-low birth weight (non-LBW, 
birth weight  2500 g) infants estimated risks of neonatal death 
at 16.4%, 2.3%, and 0.05% among newborns with five-minute 
Apgar scores of 0–3, 4–6, and 7–10, respectively.17 The study 
also demonstrated the effect of prolonged Apgar score  7 on 
mortality. Compared with infants whose Apgar score was 7–10 
at both one and five minutes, the relative risk of neonatal death 
among infants with one-minute Apgar score 0–3 decreased 
from 642 (95% CI: 442–934) to 70 (95% CI: 43–114) to 
6 (95% CI: 1–24), depending on whether the five-minute score 
remained in the 0–3 range at five minutes, or rose to the 4–6, 
or 7–10 level.17 Based on the recent evidence, relative risk for 
neonatal death associated with five-minute Apgar score 0–3 vs 
7–10 ranges from 442 to 2500 among term infants.16,17
There are also reports of association between Apgar score 
and longer-term mortality. In a 1981 US study, the reported 
infant mortality (risk of death within the first year of life) among 
non-LBW infants with five-minute Apgar scores 0–3 was 
15.5%; infant mortality was 5.7% among newborns with five-
minute Apgar scores of 4–6; and it was 1.0% among newborns 
with scores 7–10.14 The estimates were higher for LBW infants 
and those with prolonged low Apgar scores (59% if a score 0–3 
persisted for 20 minutes).14 In Norway, infant mortality among 
non-LBW children with Apgar scores 0–3, 4–6 and 7–10 at 
five minutes was 19.2%, 2.7%, and 0.3%. The estimated risks 
of death in the first eight years of life were 3.0%, 0.4%, and 
0.2% for the three Apgar score categories listed above.17
Table 2 risk factors for low Apgar scores
Parents Child
Primiparity11 Preterm birth (37 weeks)3
Use of anesthesia during labor1 Postterm birth (42 weeks)11
Maternal age at birth 19 years10,13 Low birth weight6,11
Maternal age at birth 44 years10,11 Breech presentation1
Black race10,13 Small size for gestational age11
indicators of low socioeconomic 
status7
Large size for gestational age11
Maternal smoking in pregnancy11,14 Congenital malformations3
Paternal age 44 years8 Hypoxia3
Trauma3Clinical Epidemiology 2009:1 48
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The outcome is poor among the rare infants successfully 
resuscitated after having Apgar score of 0 that lasts for ten 
minutes. A review of eight studies, together reporting on 94 
such infants, found that 78 of them died within hours or days 
of birth, while majority of the survivors had severe disability 
(eg, spastic quadriparesis).18
Apgar score and neurologic disability
Table 3 summarizes findings of studies reporting relative 
measures of association between five-minute Apgar scores 
and neurologic disability.
Cerebral palsy
Cerebral palsy was one of the first outcomes studied in relation 
to Apgar score. Nelson and Ellenberg, in the landmark study 
of 49,000 infants born in twelve US teaching hospitals, 
examined risk of cerebral palsy within the first seven years of 
life according to value of Apgar scores and duration of low 
scores.14 The pattern was similar to that observed for mortality, 
with lower score values and prolonged duration of low scores 
conferring increasingly greater risk of cerebral palsy. Among 
non-LBW infants with an Apgar score  4 lasting one minute or 
less, the risk of cerebral palsy within first seven years of life was 
0.7%, increasing to 0.9%, 4.7%, 9.1% and 57.1% if the score 
 4 persisted for 5, 10, 15, or 20 minutes (as compared with the 
background risk of 0.2%). A similarly clear monotone increase 
was lacking among the LBW infants. This was attributed to 
high neonatal mortality among LBW infants with low Apgar 
scores.14 Among 87 infants who survived after having Apgar 
score 0–3 lasting ten minutes or longer and who were free of 
cerebral palsy, eight were reported to have other handicaps (eg, 
hearing impairment, mild mental retardation) before age 7.14
In Norway, the reported risks of cerebral palsy in the 
first eight years of life among infants with Apgar scores 0–3, 
4–6, and 7–10 at five minutes were 6.8%, 2.7%, and 0.09%, 
respectively.17 The relative risk of cerebral palsy decreased in 
relation to whether Apgar scores 0–3 at one minute remained 
in that range (RR = 145; 95% CI: 85–248), or achieved by 
five minutes in the 4–6 range (RR = 57; 95% CI: 38–86) 
or the 7–10 range (RR = 17; 95% CI: 9–32). Comparisons 
were relative to infants with Apgar scores 7–10 at both one 
and five minutes. Similar patterns were observed for other 
neurodevelopmental outcomes (Table 3).17 Comparable 
findings regarding cerebral palsy were reported in a large 
registry-based case-control study in Sweden (Table 3).22
Epilepsy and seizures
In a registry-based cohort study of 130,000 singletons born 
in 1978–2001 in one Danish county, Apgar score  7 at five 
minutes was associated with an increased risk of epilepsy 
hospitalization in the first 12 years of life (RR = 2.4; 95% CI: 
1.5–3.8).21 Using data from the same period, but including all 
births in Denmark (1.5 million), another group of investi-
gators assessed risk of in- and outpatient epilepsy diagnosis 
in relation to one- and five-minute Apgar score and their 
combination. There were up to 25 years of follow-up for 
each newborn.9 The study showed a dose-response pattern 
of association between Apgar score at five minutes and long-
term risk of epilepsy. Relative risk estimates (95% CI) were 
1.45 (1.35–1.56); 1.89 (1.72–2.07); 2.44 (2.13–2.78); 4.22 
(3.78–4.72); and 7.14 (95% CI: 5.79–8.81), respectively, 
among infants whose five-minute Apgar scores were nine, 
eight, seven, 4–6, or 1–3, relative to infants with a five-
minute score of ten. The magnitude and pattern of association 
remained essentially unaffected by excluding outpatient epi-
lepsy cases or by considering epilepsy risk only among those 
without congenital malformation or cerebral palsy. The rela-
tive effects were weaker for preterm births, probably because 
of the high background risk in that group.9 The absolute risks 
of epilepsy, however, remained comparatively low even in 
the lowest five-minute Apgar score category (incidence rate, 
628 per 100,000).9 Both Danish studies showed stronger 
association of low Apgar score with epilepsy diagnosed in 
the first year of life.9,21
An earlier study using data from Swedish population 
registry reported and association between Apgar score  7 
at five minutes and risk of epilepsy in term, nonmalformed 
infants.11 Because the length of follow-up is not stated and 
it is not clear how variable follow-up was addressed, the 
estimates of association of Apgar score with epilepsy are 
hard to interpret. The study reports prevalence of (presumably 
neonatal) seizures of 6.4% for term infants with five-minute 
Apgar score  7 as compared with the prevalence of 0.09% 
among infants with scores in 7–10 range (relative risk = 71; 
95% CI: 64–74).11 Finally, in a relatively small Norwegian 
study, the prevalences of neonatal seizures corresponding to 
five-minute Apgar scores 0–3, 4–6, and 7–10 were, respec-
tively, 11.6%, 4.7%, and 0.3% among infants free of birth 
defects or major neurologic impairment at birth.19 The same 
study reported inverse relation between five-minute Apgar 
score and proportion of newborns needing ventilator treat-
ments of having feeding difficulties.19
Cognitive function
In 1975, a positive correlation was first reported between 
Apgar score at one minute and mean Bayley mental and 
motor scores in children at the age of eight months.13 More Clinical Epidemiology 2009:1 51
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recently, using data from parents’ questionnaires and national 
reports of disability benefits in Norway, five-minute Apgar 
scores  7, and particularly five-minute Apgar scores  4, 
in combination with symptoms of neonatal encephalopathy, 
were shown to be associated with increased risks of 
minor motor impairments, attention-deficit hyperactivity 
disorder-related diagnoses, and with visual impairment. 
There appeared to have been little association between Apgar 
score  7 and the examined impairments in the absence of 
neonatal encephalopathy symptoms, although the relevant 
data were sparse.19
Evidence regarding adult intelligence quotient (IQ) 
in relation to Apgar scores comes from studies based on 
linkage of birth data with results of routine IQ testing at 
conscription.15,25,26 The first such study failed to find an asso-
ciation between Apgar score and adult cognitive function.15 
A low overall prevalence of low (85) IQ scores reported 
in that study (7% instead of 15% expected given the dis-
tribution of IQ scores in the population) is an indication of 
possible selection bias, whereby conscripts with cognitive 
impairment may have been exempt from the routine IQ test-
ing.15 A study of Danish male draftees examined neurologic 
outcomes and army rejection rates among men who were 
exempt from IQ testing.26 Apgar score  7 at five minutes 
was associated with a four-fold increased risk of a neurologic 
disability in both exempt and non-exempt men and with 
six-fold risk of neurologic disability that led to army exemp-
tion. There was a modest association between five-minute 
Apgar score  7 and prevalence of IQ scores in the bottom 
quartile (prevalence ratio = 1.33 compared with five-minute 
Apgar score of 10, Table 3).26 In the largest study to date 
(170,000 Swedish conscripts), the increase in the risk of 
low cognitive function associated with five-minute Apgar 
score  7 (vs 7–10) was nearly identical (odds ratio = 1.35) 
despite different types of IQ tests used to measure cogni-
tive function.25 The study showed little association between 
briefly (5 minutes) low Apgar score and subsequent 
cognitive performance.25 Reported mean decrease in IQ 
associated with Apgar score  7 at five minutes amounts 
to one-tenth of one standard deviation, ranging from 1.2 to 
1.8 IQ points.24–26
Other neurologic outcomes
A recent case-control study reported a three-fold increase 
in risk of infantile autism associated with five-minute 
Apgar score  7.20 In addition there is evidence suggesting 
association of low Apgar scores with neonatal auditory 
impairment.23
Discussion
Most studies consistently show that low Apgar scores, partic-
ularly when prolonged, are associated with greater risk of 
neonatal death and with subsequently diagnosed neurologic 
disability.
Low Apgar score is associated with correlates of brain 
damage, such as hypoxic–ischemic encephalopathy (HIE) 
and acidemia (pH  7.0 of the umbilical-cord blood). 
Reported prevalence of HIE from a recent study was 70%, 
14%, and 0% among term, malformation-free infants with 
five-minute Apgar score 0–3, 4–6, and 7–10, respectively.27 
Acidemia reportedly occurs in about 38% of term infants with 
five-minute Apgar scores  7.28 Acidemia may be indicative 
of hypoxia, which in turn could lead to HIE. HIE may cause 
neurologic dysfunction in term newborns,29,30 and it accounts 
for about 20% of cerebral palsy cases.31 Severe HIE is associ-
ated with up to 75% infant mortality.32 The co-occurrence 
of low Apgar scores with markers of hypoxia and with HIE 
is one possible mechanism underlying its association with 
death and neurologic disability.
Neurologic disability develops by a number of 
mechanisms, some of which involve HIE, but many still 
unknown. A low value of Apgar score may reflect the action 
of different sets of prenatal or perinatal factors that either 
cause neurologic morbidity or are markers of increased 
susceptibility.21 Furthermore, common causes that underlie 
infant’s failure to respond to resuscitation and its poor long-
term neurologic prognosis could also partially account for 
the observed associations. There are likely to be individual 
differences with respect to the amount of asphyxia required 
to produce appreciable brain damage in survivors with low 
Apgar scores.14
Although relative risks reported for the associations 
between low Apgar scores and risks of neurologic disability 
are rather large, the corresponding absolute risks are low. 
Furthermore, majority of children with clinical disability 
do not have a history of a low Apgar score.3,14 This is hardly 
surprising given that there is imperfect correlation between 
low Apgar scores and conditions that predispose to neurologic 
damage, such as HIE. These conditions, in turn, imperfectly 
correlate with subsequent neurologic morbidity,33,34 further 
contributing to the dilution of the observed associations.
Among preterm infants, low values of some Apgar score 
components (eg, reflex irritability, muscle tone, respiratory 
effort) reflect physiological prematurity rather than newborn 
compromise.35,36 Therefore, the degree of correlation between 
low Apgar scores and potential markers of brain damage is 
weaker in preterm than in term infants. For example, the Clinical Epidemiology 2009:1 52
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shorter the gestation, the weaker the correlation appears to 
be between low Apgar score and acidosis (ie, larger pro-
portions of preterm babies have low Apgar scores without 
evidence of acidosis).37 Similarly, relative risks of abnormal 
clinical findings associated with low Apgar scores in the 
first hours of life appear to be decreasing with decreasing 
gestational age.36 Preterm infants are at greater risk of adverse 
outcome regardless of Apgar score. Thus, the de-coupling of 
low Apgar score from signs of potential neurologic damage 
among preterm infants may explain weaker associations 
between low Apgar scores and risk of neurologic disability.9,14 
At the same time, stronger association of low Apgar score 
with adverse outcome among term infants may be viewed 
as a strength, rather than a limitation, of Apgar score, since 
in term babies, Apgar score may indicate vulnerabilities that 
are not known or apparent.
Apgar score is a reliable index of a newborn’s condition 
immediately after birth, particularly in guiding decisions 
regarding resuscitation and in predicting neonatal death.16 
The associations of low Apgar scores with neurologic 
disability have been shown with sufficient consistency, but 
the low associated absolute risks do not warrant use of low 
Apgar score to predict long-term neurologic prospects for 
individual infants. Rather, the associations may be taken 
as evidence of the potential biologic mechanisms that link 
prenatal and perinatal events with neurodevelopment.
Search strategy
I searched Medline for English language articles with 
abstracts, published from January 1st, 1999 to February 20, 
2009, using the term ‘Apgar score’ in the title or abstract. 
I examined Medline-provided related articles, and also 
manually searched references of published papers.
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